Centre Hospitalier Universitaire Dijon
Clinical trials sponsored by Centre Hospitalier Universitaire Dijon, explained in plain language.
-
Steroid flash before cancer surgery may halve complications, major trial underway
Disease control OngoingThis study tests whether giving a high dose of corticosteroids just before surgery for digestive cancers can reduce serious complications and improve recovery. Inflammation during surgery is linked to worse outcomes, and earlier research suggests steroids may cut complication ris…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Cheaper drug may match expensive biologic in artery disease
Disease control OngoingThis study compares two treatments—methotrexate and tocilizumab—for giant cell arteritis, a disease that causes inflammation in large arteries. About 230 adults over 50 will receive one of the drugs for 12 months to see which better prevents relapses while reducing steroid use. T…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New study tests best way to stop arthritis drug without relapse
Disease control OngoingThis study looks at 120 adults with giant cell arteritis (a type of blood vessel inflammation) who are stable on tocilizumab. Researchers want to see if gradually reducing the drug is better than stopping it all at once for preventing the disease from flaring up again. Participan…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 01, 2026 15:58 UTC